Skip to Content
Merck
CN
Search Within
Topic
Content Type
Collections
Topic Area
Product Category
Applications

126275-19-2

Applied Filters:
Keyword:'126275-19-2'
Showing 1-10 of 1724 results for "126275-19-2" within Site Content
Coronavirus COVID-19 (SARS-CoV-2) Detection, Characterization, Vaccine and Therapy Production
We've consolidated our COVID-19 detection, characterization, and vaccine production product offers to help researchers responding to the coronavirus pandemic.
MILLIPLEX® Multiplex Assays for COVID-19 (SARS-CoV-2) Research Applications
MILLIPLEX® multiplex assays help to better understand the immune response to COVID-19 (SARS-CoV-2), including cytokine storm. Our MILLIPLEX® multiplex immunoassays offer researchers the ability to simultaneously quantitate a large number of analytes critical to understanding the immune response in humans.
IgG Antibodies Against SARS-CoV-2 Correlate to Days from Symptom Onset in COVID-19 Positive Patients
IgG Antibodies Against SARS-CoV-2 Correlate to Days from Symptom Onset in COVID-19 Positive Patients
2-Propanol
Discover our range of 2-propanol solvents. Ideal for chemical reactions, extractions, chromatography techniques, and other applications.
Merck & Baylor College Covid-19 Collaboration
Merck and Baylor College extend collaboration to accelerate Covid-19 manufacturing platform for Phase 1 clinical trials.
Stimuli-responsive Poly(2-isopropyl-2-oxazoline) Materials
PiPrOx-based polymers exhibit diverse stimuli-responsive properties, showcased in recent developments for functional polymer systems.
Rh2(esp)2 Catalyst
New! Rh2(esp)2, and exceptionally efficient and selective catalyst for C-H amination.
2-Hydroxyglutarates Analysis by LCMS
Reversed phase application for the analysis of S-2-hydroxyglutaric acids and R-2-hydroxyglutaric acids by chiral LCMS, using a CHIROBIOTIC® R Column.
Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine
Merck and The Jenner Institute today announced that The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
Merck Supports Eijkman Institute to Expedite Covid-19 Vaccine Development Research
Merck today announced the donation of research instruments and materials worth IDR 1.2 billion (€ 74,000) to support the efforts of Eijkman Institute for Molecular Biology, Indonesia.
Page 1 of 173